LX4211

Lexicon Pharmaceuticals up 25% on drug trial
Marketwatch
Mon, 04/14/14 - 08:14 am
Lexicon Pharmaceuticals
type 1 diabetes
LX4211
The Future of Diabetes Control: Treat the Cause, Not the Symptom
Wall St Cheat Sheet
Thu, 12/5/13 - 10:04 am
diabetes
Novo Nordisk
Prandin
Merck
Lexicon Pharmaceuticals
LX4211
PAZ320
Boston Therapeutics
7 Disruptive Drugs for the Next Decade
Motley Fool
Wed, 10/9/13 - 10:42 pm
Tecfidera
Biogen Idec
Bristol-Myers Squibb
Eliquis
Pfizer
Roche
Kadcyla
Immunogen
sofosbuvir
Gilead
ibrutinib
Pharmacyclics
Sarepta
eteplirsen
LX4211
Lexicon Pharmaceuticals
Lexicon surges on diabetes drug study data
Yahoo/AP
Tue, 10/1/13 - 11:05 am
Lexicon
diabetes
LX4211
Lexicon Pharma's Never-Ending Diabetes Drug Partner Talks
The Street
Thu, 08/1/13 - 09:14 am
Lexicon Pharmaceuticals
LX4211
type 2 diabetes
diabetes
Lexicon Pharma Falls on Concerns Raised by Merck-Pfizer Diabetes Partnership
TheStreet.com
Mon, 04/29/13 - 11:48 am
Merck
Pfizer
Lexicon Pharmaceuticals
diabetes
ertugliflozin
LX4211
Lexicon Pharma: Blockbuster Potential From A Diabetes Drug
TheStreet.com
Tue, 10/16/12 - 10:40 am
diabetes
Lexicon Pharmaceuticals
LX4211
sodium-dependent glucose transporter
Diabetes, Carcinoid Syndrome Drive Lexicon's Late-Stage Pipeline
Yahoo/Reuters
Fri, 10/12/12 - 12:11 pm
diabetes
Lexicon Pharmaceuticals
carcinoid syndrome
LX1032
LX4211
Lexicon diabetes drug meets trial goal, shares up
Reuters
Mon, 06/25/12 - 11:21 am
Lexicon
diabetes
LX4211
Lexicon Presents Data Regarding the Mechanism of Action and Safety of LX4211 at American Diabetes Association Meeting
Yahoo/PR NewsWire
Sat, 06/9/12 - 12:29 pm
LX4211
Lexicon Pharmaceuticals
diabetes
type 2 diabetes
A Biotech Roller Coaster
Motley Fool
Sat, 01/8/11 - 11:57 am
Lexicon Pharmaceuticals
diabetes
LX4211
Merck
obesity
Amylin
Januvia
Onglyza
Bristol-Myers Squibb
AstraZeneca
Lexicon Pharma shares soar after study reported
Yahoo/AP
Fri, 01/7/11 - 07:18 am
Lexicon Pharmaceuticals
diabetes
LX4211